As of 2024-09-09, the Relative Valuation of Abbvie Inc (ABBV) is 156.55 USD. This relative valuation is based on P/E multiples. With the latest stock price at 193.40 USD, the upside of Abbvie Inc based on Relative Valuation is -19.1%.
The range of the Relative Valuation is 105.07 - 206.04 USD.
| Range | Selected | |
| Trailing P/E multiples | 34.8x - 59.9x | 47.6x |
| Forward P/E multiples | 38.1x - 56.4x | 46.3x |
| Fair Price | 105.07 - 206.04 | 156.55 |
| Upside | -45.7% - 6.5% | -19.1% |
| Date | P/E |
| 2024-09-06 | 63.98 |
| 2024-09-05 | 63.81 |
| 2024-09-04 | 65.18 |
| 2024-09-03 | 65.40 |
| 2024-08-30 | 64.95 |
| 2024-08-29 | 64.57 |
| 2024-08-28 | 64.65 |
| 2024-08-27 | 64.82 |
| 2024-08-26 | 65.32 |
| 2024-08-23 | 65.36 |
| 2024-08-22 | 64.97 |
| 2024-08-21 | 65.02 |
| 2024-08-20 | 64.89 |
| 2024-08-19 | 65.13 |
| 2024-08-16 | 64.15 |
| 2024-08-15 | 63.98 |
| 2024-08-14 | 63.85 |
| 2024-08-13 | 63.27 |
| 2024-08-12 | 62.92 |
| 2024-08-09 | 62.84 |
| 2024-08-08 | 62.99 |
| 2024-08-07 | 62.04 |
| 2024-08-06 | 61.44 |
| 2024-08-05 | 60.99 |
| 2024-08-02 | 62.62 |
| 2024-08-01 | 62.76 |
| 2024-07-31 | 61.31 |
| 2024-07-30 | 61.79 |
| 2024-07-29 | 60.19 |
| 2024-07-26 | 61.26 |
| 2024-07-25 | 60.27 |
| 2024-07-24 | 58.30 |
| 2024-07-23 | 57.28 |
| 2024-07-22 | 57.44 |
| 2024-07-19 | 57.01 |
| 2024-07-18 | 56.62 |
| 2024-07-17 | 57.99 |
| 2024-07-16 | 55.98 |
| 2024-07-15 | 55.59 |
| 2024-07-12 | 56.33 |
| 2024-07-11 | 56.21 |
| 2024-07-10 | 55.63 |
| 2024-07-09 | 55.60 |
| 2024-07-08 | 55.09 |
| 2024-07-05 | 55.33 |
| 2024-07-03 | 54.20 |
| 2024-07-02 | 54.91 |
| 2024-07-01 | 56.36 |
| 2024-06-28 | 56.75 |
| 2024-06-27 | 55.91 |